 EFFICACY, TOLERABILITY AND SAFETY OF INTRAMUSCULAR INJECTIONS OF PLX PAD FOR THE TREATMENT OF SUBJECTS WITH CRITICAL LIMB ISCHEMIA CLI WITH MINOR TISSUE LOSS WHO ARE UNSUITABLE FOR REVASCULARIZATION: 